
AbbVie Revenue Rises on Strength in Immunology, Neuroscience
来源:WSJ发布于 2026-10-30
The pharmaceutical company boosted its profit outlook for the year, and raised its quarterly dividend as both third-quarter results and full-year guidance came in above expectations.
相关标的:ABBV
本文内容来自外部来源,点击「继续访问」将跳转到原始发布站点。